FMR LLC

Position in ORKA — Oruka Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in ORKA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$862,016,073

+$497,505,758 QoQ

Shares Held

9,057,645

+21.9% QoQ

Ownership

13.7%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 254 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ORKA ranks #18 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$862,016,073	9,057,645	+21.9%	Shares	Defined	2026-08-13
2026-03-31	$364,510,315	7,431,403	+2.3%	Shares	Defined	2026-05-15
2025-12-31	$220,092,548	7,261,384	+0.1%	Shares	Defined	2026-02-17
2025-09-30	$139,564,050	7,257,621	+29.2%	Shares	Defined	2025-11-13
2025-06-30	$62,960,638	5,616,471	+1.0%	Shares	Defined	2025-08-14
2025-03-31	$57,064,149	5,561,808	+0.9%	Shares	Defined	2025-05-12
2024-12-31	$106,883,496	5,512,300	+17.7%	Shares	Defined	2025-02-13
2024-09-30	$114,763,172	4,682,300	—	Shares	Defined	2024-11-13
2024-03-31 ABIO	—	201	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.